These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
283 related items for PubMed ID: 28321153
1. P-glycoprotein multidrug transporter in inflammatory bowel diseases: More questions than answers. Cario E. World J Gastroenterol; 2017 Mar 07; 23(9):1513-1520. PubMed ID: 28321153 [Abstract] [Full Text] [Related]
2. Toll-like receptors in the pathogenesis of chemotherapy-induced gastrointestinal toxicity. Cario E. Curr Opin Support Palliat Care; 2016 Jun 07; 10(2):157-64. PubMed ID: 26986508 [Abstract] [Full Text] [Related]
3. The mdr1a-/- mouse model of spontaneous colitis: a relevant and appropriate animal model to study inflammatory bowel disease. Wilk JN, Bilsborough J, Viney JL. Immunol Res; 2005 Jun 07; 31(2):151-9. PubMed ID: 15778512 [Abstract] [Full Text] [Related]
4. TLR signaling modulates side effects of anticancer therapy in the small intestine. Frank M, Hennenberg EM, Eyking A, Rünzi M, Gerken G, Scott P, Parkhill J, Walker AW, Cario E. J Immunol; 2015 Feb 15; 194(4):1983-95. PubMed ID: 25589072 [Abstract] [Full Text] [Related]
5. NLRX1 Modulates Immunometabolic Mechanisms Controlling the Host-Gut Microbiota Interactions during Inflammatory Bowel Disease. Leber A, Hontecillas R, Tubau-Juni N, Zoccoli-Rodriguez V, Abedi V, Bassaganya-Riera J. Front Immunol; 2018 Feb 15; 9():363. PubMed ID: 29535731 [Abstract] [Full Text] [Related]
6. Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a-/-) mice. Maggio-Price L, Shows D, Waggie K, Burich A, Zeng W, Escobar S, Morrissey P, Viney JL. Am J Pathol; 2002 Feb 15; 160(2):739-51. PubMed ID: 11839595 [Abstract] [Full Text] [Related]
7. Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy. Silva R, Vilas-Boas V, Carmo H, Dinis-Oliveira RJ, Carvalho F, de Lourdes Bastos M, Remião F. Pharmacol Ther; 2015 May 15; 149():1-123. PubMed ID: 25435018 [Abstract] [Full Text] [Related]
8. The effects of dietary curcumin and rutin on colonic inflammation and gene expression in multidrug resistance gene-deficient (mdr1a-/-) mice, a model of inflammatory bowel diseases. Nones K, Dommels YE, Martell S, Butts C, McNabb WC, Park ZA, Zhu S, Hedderley D, Barnett MP, Roy NC. Br J Nutr; 2009 Jan 15; 101(2):169-81. PubMed ID: 18761777 [Abstract] [Full Text] [Related]
9. The importance of the polymorphisms of the ABCB1 gene in disease susceptibility, behavior and response to treatment in inflammatory bowel disease: A literature review. Petryszyn PW, Wiela-Hojeńska A. Adv Clin Exp Med; 2018 Oct 15; 27(10):1459-1463. PubMed ID: 30412370 [Abstract] [Full Text] [Related]
10. Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis. Annese V, Valvano MR, Palmieri O, Latiano A, Bossa F, Andriulli A. World J Gastroenterol; 2006 Jun 21; 12(23):3636-44. PubMed ID: 16773678 [Abstract] [Full Text] [Related]
11. Gut microbiota regulation of P-glycoprotein in the intestinal epithelium in maintenance of homeostasis. Foley SE, Tuohy C, Dunford M, Grey MJ, De Luca H, Cawley C, Szabady RL, Maldonado-Contreras A, Houghton JM, Ward DV, Mrsny RJ, McCormick BA. Microbiome; 2021 Sep 07; 9(1):183. PubMed ID: 34493329 [Abstract] [Full Text] [Related]
12. Contentious host-microbiota relationship in inflammatory bowel disease--can foes become friends again? Satokari R. Scand J Gastroenterol; 2015 Jan 07; 50(1):34-42. PubMed ID: 25523554 [Abstract] [Full Text] [Related]
13. Immunopathophysiology of inflammatory bowel disease: how genetics link barrier dysfunction and innate immunity to inflammation. Mehta M, Ahmed S, Dryden G. Innate Immun; 2017 Aug 07; 23(6):497-505. PubMed ID: 28770665 [Abstract] [Full Text] [Related]
14. Absence of association between the multidrug resistance (MDR1) gene and inflammatory bowel disease. Oostenbrug LE, Dijkstra G, Nolte IM, van Dullemen HM, Oosterom E, Faber KN, de Jong DJ, van der Linde K, te Meerman GJ, van der Steege G, Kleibeuker JH, Jansen PL. Scand J Gastroenterol; 2006 Oct 07; 41(10):1174-82. PubMed ID: 16990202 [Abstract] [Full Text] [Related]
15. A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. Panwala CM, Jones JC, Viney JL. J Immunol; 1998 Nov 15; 161(10):5733-44. PubMed ID: 9820555 [Abstract] [Full Text] [Related]
16. Critical role for P-glycoprotein expression in hematopoietic cells in the FVB.Mdr1a(-/-) model of colitis. Staley EM, Dimmitt RA, Schoeb TR, Tanner SM, Lorenz RG. J Pediatr Gastroenterol Nutr; 2011 Dec 15; 53(6):666-73. PubMed ID: 21681110 [Abstract] [Full Text] [Related]
17. The Intestinal Microbiota in Inflammatory Bowel Disease. Becker C, Neurath MF, Wirtz S. ILAR J; 2015 Dec 15; 56(2):192-204. PubMed ID: 26323629 [Abstract] [Full Text] [Related]
18. Functions of innate immune cells and commensal bacteria in gut homeostasis. Kayama H, Takeda K. J Biochem; 2016 Feb 15; 159(2):141-9. PubMed ID: 26615026 [Abstract] [Full Text] [Related]
19. Cellular and Molecular Therapeutic Targets in Inflammatory Bowel Disease-Focusing on Intestinal Barrier Function. Schoultz I, Keita ÅV. Cells; 2019 Feb 22; 8(2):. PubMed ID: 30813280 [Abstract] [Full Text] [Related]
20. MDR1 deficiency impairs mitochondrial homeostasis and promotes intestinal inflammation. Ho GT, Aird RE, Liu B, Boyapati RK, Kennedy NA, Dorward DA, Noble CL, Shimizu T, Carter RN, Chew ETS, Morton NM, Rossi AG, Sartor RB, Iredale JP, Satsangi J. Mucosal Immunol; 2018 Jan 22; 11(1):120-130. PubMed ID: 28401939 [Abstract] [Full Text] [Related] Page: [Next] [New Search]